Skip to content

To Assess The Efficacy Of Mandukparni Siddhataila Shirobasti In Vishada (Depression)

Clinical Trial For Assessing The Efficacy Of Mandukparni Siddhataila Shirobasti in The Management Of Vishada (Depression) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108138
Enrollment
40
Registered
2026-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F439- Reaction to severe stress, unspecified

Interventions

None listed

Sponsors

CSMSS Ayurved Mahavidyala and Rugnalaya Kanchanwadi Aurangabad Maharashtra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Dignosed patients of vishada (Depression) having clinical features like Dukkhtvam Nidravaishamya, Manah khedah Chittodvega Asiddhi bhaya Anabhiruchi Age cadre 18 to 50 years Patients of either gender, irrespective of socioeconomic status Patient willing to sign the informed consent form Patient with history of Vishada (Depression) less than one year

Exclusion criteria

Exclusion criteria: Patient age group of below 18 and above 50 years Shirobasti ayogya Patient which are not willing to do shirobasti Patient with major depressive disorder Pregnant women and children Patients with chronic illness like Cancer Hypertension Diabetes Mellitus Hyperthyroidism and Hypothyroidism Patients with Suicidal tendency and thoughts

Design outcomes

Primary

MeasureTime frame
Chittodvega (Anxiety) Anabhiruchi (Loss of Interest) Nidravaishamya (Sleep disturbances)Timepoint: 0 and 15th day

Secondary

MeasureTime frame
Dukkhatvam (Feeling of sadness or depressed mood) Manah khedah (Inappropriate guilt) Asiddhi bhaya( Fear of failure to perform)Timepoint: 0 & 15th day

Countries

India

Contacts

Public ContactDr Shivam Ramkishan Parihar

C.S.M.S.S Ayurved Mahavidyala And Rugnalaya Kanchanwadi Aurangabad

uneralkar@gmail.com9850035061

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026